Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Brett Case

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature Medicine|July 12, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Nature Immunology|October 8, 2020
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19Matthew C Woodruff, Richard P Ramonell, Doan C Nguyen, et al.
Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.
Science (New York, N.Y.)|September 25, 2020
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanismsM Alejandra Tortorici, Martina Beltramello, Florian A Lempp, et al.
Nature|July 16, 2020
Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Science Translational Medicine|April 12, 2022
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in miceAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature Medicine|July 12, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Nature Immunology|October 8, 2020
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19Matthew C Woodruff, Richard P Ramonell, Doan C Nguyen, et al.
Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.
Science (New York, N.Y.)|September 25, 2020
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanismsM Alejandra Tortorici, Martina Beltramello, Florian A Lempp, et al.
Nature|July 16, 2020
Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Science Translational Medicine|April 12, 2022
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in miceAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Pageof 9